Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 2Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 63INDUSTRY 63NIH 20NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Astrocytoma 29Central Nervous System Neoplasms 28Unspecified Adult Solid Tumor, Protocol Specific 18Ovarian Neoplasms 17Oligodendroglioma 17Medulloblastoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lung Neoplasms 15Optic Nerve Glioma 14Neuroblastoma 14Lymphoma 14Carcinoma, Non-Small-Cell Lung 14Leukemia 13Glioblastoma 13Familial ependymoma 12Choroid Plexus Neoplasms 12Carcinoma, Ovarian Epithelial 12Fallopian Tube Neoplasms 11Burkitt Lymphoma 11Breast Neoplasms 11Sarcoma 10Colorectal Neoplasms 9Brain Neoplasms 9Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Brenner Tumor 8Lymphoma, Non-Hodgkin 7Glioma 7Colonic Neoplasms 7Uterine Cervical Neoplasms 6

Interventions

Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all
NCT00004932 2014-02-21

STI571 in Treating Patients With Recurrent Leukemia

Children's Oncology Group

Phase 1 Completed
31 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡